CD8A and neoplasm: Cell sorting of tumor immune infiltrates indicated that SB225002 treatment reduced myeloid-derived suppressor cells (MDSC) and Treg cells, and increased CD8+/CD4+ T cells, NK cells, macrophages and dendritic cells (Fig. 3c,d).